The most crucial function of these transporters is usually to terminate monoamine transmission by reuptake in the released neurotransmitters. Interaction of psychoactive medicines with the monoamine transporters inhibits this reuptake leading to an increase in the concentration of dopamine, norepinephrine and serotonin within the synaptic cleft.[9]